Shardul Amarchand Mangaldas & Co. advised Novo Holdings A/S on its investment in MedGenome Inc.

Shardul Amarchand Mangaldas advised Novo Holdings A/S in connection with its investment in Medgenome Inc., as a part of the company’s USD 47.5 million Series E funding round, co-led by Novo Holdings A/S and Maj Invest.   This investment will enable the company in expanding its genomics and integrated diagnostics solutions across India and other… Read More +

countinue reading